From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Jacqueline A Harbron Newsgroups: bionet.diagnostics Subject: Re: Diagnsotics Briefing Date: 12 Nov 1996 07:05:12 -0800 Organization: Nildram On-Line Lines: 16 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a3n8$fng@net.bio.net> NNTP-Posting-Host: net.bio.net Thanks to thos who pointed out that the URL was incomplete :( Should be: http://homepages.nildram.co.uk/~harbron/NEWSLETT/dbindex.htm where you will also find this month's TABULATIONS of literature relevent to all engaged in diagnostics research and development. Stuart Harbron, PhD The Enzyme Technology Consultancy http://www.nildram.co.uk/~harbron From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Kevin O'Donnell Newsgroups: bionet.diagnostics Subject: Apologies Date: 12 Nov 1996 07:30:45 -0800 Organization: Scottish Agricultural Science Agency Lines: 10 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a575$i8c@net.bio.net> NNTP-Posting-Host: net.bio.net I apologise for the lack of messages on bionet.diagnostics for the past 2 weeks. I was unexpectedly in hospital and unable to approve messages. Things should now return to normal. Kevin Dr Kevin O'Donnell Diagnostics and Molecular Biology SASA Edinburgh From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: Programmer Wanted - Corneal Diagnostics Date: 12 Nov 1996 07:16:14 -0800 Organization: America Online, Inc. (1-800-827-6364) Lines: 45 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a4bu$h1s@net.bio.net> NNTP-Posting-Host: net.bio.net Job Title: Junior Programmer Placement Type: Permanent, Direct-hire, Exempt Position with Benefits Reports to: Manager of Research and Development Work Schedule: Monday - Friday, 1st shift, Approximately 40 hours a week. Job Description: This position is for a junior programmer to work in computer program development in a small Research and Development department of a software producer in Northwest Houston. The department in which this programmer will work consists of a Manager and three to four programmers. Approximately 70% of the programmers time will be devoted to programming and development, where as, the remaining approximately 30% of the time will be devoted to assorted tasks related to testing, evaluation, installation, release and technical support. The platforms are exclusively PC-based and there is no requirements for extensive minicomputer, main-frame computer, Mac or UNIX experience. Minimum Requirements: Graduation from an accredited four-year college or university with a degree in Computer Science or electrical engineering. Applicants with a Masters Degree in these disciplines will be given preference, but, a Masters Degree is not required. Intimate familiarity and demonstrable successful project-level experience with the following programs: 1. Microsoft Windows 3.1, Microsoft Windows for Workgroups 3.11 and Windows 95 2. C and C++ programming languages 3. Visual Basic 4. Microsoft Access 5. Various PC graphics programs to include presentation graphics Must have familiarity with and demonstrated successful project-level experience with PC platforms and PC networks Familiarity with communications program development is much preferred. Additional Information: Candidate must be made aware that there is a strong possibility of the company relocating to northern California within 6-12 months, and, the position will transfer with the company. Applicants willing to relocate with the company are much preferred to those unwilling to relocate. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. ssihouston@aol.com http://www.net-solutions.com/ScienStaff 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929, FAX: 713-640-1942 From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Jacqueline A Harbron Newsgroups: bionet.diagnostics Subject: Diagnsotics Briefing Date: 12 Nov 1996 07:07:44 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 39 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a3s0$g8p@net.bio.net> NNTP-Posting-Host: net.bio.net Give yourself time to create! DIAGNOSTICS BRIEFING reviews all the diagnostics literature, so you get on with what you're best at - managing your scientists and coming up with new ideas. Published monthly in an easy to digest format it contains all the relevant papers on diagnostics. This means that you have potent and relevant information at your fingertips making you well-briefed and well-informed. All the information is in one compact publication which means you make faster progress, cutting out much of the arduous library work. We do the survey so you have time to think. To make it easy to find what you need, DIAGNOSTICS BRIEFING: is CATEGORISED by Assays in Development; Disease Investigation; Assay Evaluation; Comparative Studies; Review Papers; Enabling Technology. is TABULATED by Infection and Disease features REPORTS on Assays in Development and Enabling Technology For further details point your browser at http://homepages.nildram.co.uk where you will also find this month's TABULATIONS of literature relevent to all engaged in diagnostics research and development. Stuart Harbron, PhD The Enzyme Technology Consultancy http://www.nildram.co.uk/~harbron From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - CLINICAL ENG. TECH Date: 12 Nov 1996 07:15:15 -0800 Organization: America Online, Inc. (1-800-827-6364) Lines: 104 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a4a3$gt1@net.bio.net> NNTP-Posting-Host: net.bio.net CLINICAL ENGINEERING TECHNICIANS (CET, 2) - Austin & Houston, Texas Area. Summary: This individual will be responsible for operating prototype, noninvasive, light based, clinical data collection systems and pre-production and production units of same in conjunction with client physicians and nurse practitioners. The CET will operate systems in laboratories at the Austin facilities, and in gynecological laboratories and clinics in Houston and other national sites. The CET will be trained in the operation of multiple systems types, will perform minor maintenance and troubleshooting, will collect clinical data and device performance data, and will be responsible for efficient data storage and transmission. The individual will be trained to perform under ISO 9000, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), current Good Manufacturing Practice (GMP), and other relevant, world-class medical device performance standards. As a representative of the company, the CET will interact daily with patients, physicians, scientists, vendors and team members while maintaining a professional demeanor and appearance. Duties and Responsibilities (successful candidates will have experience with each of the following items): * Learn the operation and limited troubleshooting of prototype photonic clinical systems * Learn relevant aspects of Design Control, learn regulations of the federal Food and Drug Administration (FDA), cGMP, GCP, GLP and learn and apply company Standard Operating Procedures (SOPs) * Operate prototype diagnostic devices in a clinical setting in accordance with training * Collect patient data as required using Clinical Data Collection forms * Observe performance of equipment in the hands of clinical users * Observe patient interaction with the patient contact system * Decontaminate patient contact systems * Prepare detailed written reports of operator and patient interaction with systems * Prepare written design suggestions and performance reports for equipment designers * Perform and document equipment experiments with animal tissue, human tissue, and optical models * Collect, store and transmit digital data files * Interact with clinical specialists and patients as part of a clinical research team * interact with suppliers and contractors with purchase orders, confidentiality agreements, contracts, drawings, e-mail, fax and phone communications * Operate diagnostic devices in compliance with the laws and regulations of the United States and the FDA * Protect patient confidentiality in conformance with the requirements of the Department of Health and Human Services and the FDA Minimum Qualifications Include: Education: At least a four-year degree in Biology, Engineering, Nursing, Medical Laboratory Technology or physical sciences. Advanced degree holders in these fields and particularly in the fields of engineering are encouraged to apply. Specialized Skills and Knowledge Required: * Familiarity with learning and complying with regulations. FDA, ISO 9000, cGMP, GLP, and GCP knowledge is essential. * Familiarity with operating and minor troubleshooting of optical elements such as fiber optics, lenses and mirrors, lamps and lasers. Skill in the use of power meters or spectrometers is essential. * Familiarity with operating and minor troubleshooting of electronic instruments. Previous experience with or skill in the use of an oscilloscope is essential. * Meticulous documentation skills, including familiarity with specifications, experiment reports or lab notebooks and purchase orders. Skill in data file management and data manipulation. * Skill in the use of Microsoft Word and Excel. Skill in transferring data on the Internet. Skill in the use of Labview or Matlab would be beneficial. Experience Required: * Experience working in a rapid paced environment, self-supervising, setting and performing priorities, and communicating efforts and results to other members of a Project Team. * Experience in verbal and written communication with physicians, patients, professionals and suppliers. * Experience with data file collection, creation, transfer, manipulation and storage. * Experience with equipment calibration logging, patient data accrual and spread sheet use. * The individual will be required to maintain a professional appearance at all times. LOCATION: Duties will be performed in laboratories at Austin, Texas about three days per month. Initial training may require two weeks in Austin, Texas . Most of the duties will be performed in hospital settings in Houston, Texas. Some future travel including short term assignments will be required to train and support equipment operators in other cities in the U.S. and overseas. The are no relocation expenses available for this position. Please send your resume to: David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. ssihouston@aol.com http://www.net-solutions.com/ScienStaff 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929, FAX: 713-640-1942 From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: BIOSCI Administrator Newsgroups: bionet.diagnostics Subject: BIOSCI/bionet miniFAQ & Fundraiser Date: 12 Nov 1996 07:01:44 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 239 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a3go$fin@net.bio.net> NNTP-Posting-Host: net.bio.net (LAST REVISION: 30-JUL-95) This BIOSCI "miniFAQ" is designed to answer the questions that come up the *most frequently*. The main BIOSCI FAQ (Frequently Asked Questions) is accessible on the World Wide Web at URL http://www.bio.net/. If you can not find an answer to your question in this or other documentation, the BIOSCI technical support staff answers e-mail queries sent to biosci-help@net.bio.net We can only answer questions about the use of the newsgroups and mailing lists. We unfortunately do not have the staff to do Internet information searches or answer scientific questions. Please post those to the appropriate BIOSCI/bionet newsgroups. Contents: -------- 0) BIOSCI NEEDS YOUR SUPPORT!! 1) Using the WWW to access the BIOSCI/bionet newsgroups. 2) What to do about "spams," i.e., junk mail, ads, etc. 3) Examples of subscribing and unsubscribing to the mailing lists. 4) The BIOSCI user address and research interest directory. 0) BIOSCI NEEDS YOUR SUPPORT!! ------------------------------ BIOSCI's government funding has been expended, and we are now operating solely from advertising revenue that we have raised from our Web site at http://www.bio.net/. We need just a few minutes of your time to help us serve you. You can do two important things which will take very little time for you individually and will immensely help us continue to help you. First, please use our WWW system at http://www.bio.net/ to access the archives. You can post or reply to messages via your Web browser as described in item #1 below. Your usage helps attract sponsors. If you contact any of our sponsors, please be sure to thank them for supporting BIOSCI. It is critical for them to get this feedback if they are to continue their sponsorship for the long term. Second, if you work for a company or organization that provides products or services of interest to the biology community, please pass this message on to your marketing or marketing communications department or other appropriate group. Please ask them to help support BIOSCI by sponsoring our Web site and explain the uses and benefits of the system to the biology community. If they are interested, they can then contact us for further information at our tech support address, biosci-help@net.bio.net. 1) Using the WWW to access the BIOSCI/bionet newsgroups. -------------------------------------------------------- As of 10 December 1995, all BIOSCI/bionet full newsgroups are accessible through the World Wide Web (WWW) at URL http://www.bio.net. One can read and reply publicly or privately to both recent postings and archived messages through one's Web browser if it is configured properly to send e-mail. Each newsgroup is equipped with its own WAIS index. The main BIOSCI home page also has access to the BIO-JOURNALS Table of Contents database WAIS index and the BIOSCI user address database described in another item further below. 2) What to do about "spams," i.e., junk mail, ads, etc. ------------------------------------------------------- BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups), mailing lists, and a hypermail archive at URL http://www.bio.net/. The same postings are distributed on all media (except for a small number of mailing-list-only groups at net.bio.net). Unfortunately it is becoming a despicable practice on the Internet (by a few people out to make a fast buck) to do automated mass postings to thousands of newsgroups and mailing lists. These attempts to grab free advertising are refered to as "spams" in the usual, somewhat boneheaded, net terminology. USENET is more susceptible to this practice, and many spams originate on the USENET groups and then are passed on to the mailing lists. However, spammers also get lists of mailing addresses and hit these too, so neither medium is immune. What should you do personally if you get junk mail? --------------------------------------------------- Just delete it and move on without reading it further. Filing a protest is becoming increasingly useless because spammers are often disguising the addresses where the messages are sent from. Unless you really understand Internet mail systems, your attempt at protest by sending replies to the message will often end up being sent to the address of an innocent person that the spammer is victimizing. What can BIOSCI/bionet do to protect its newsgroups? ---------------------------------------------------- The only solution currently available is to moderate the newsgroup. If this newsgroup is already moderated, then you are in good shape. Moderation protects the USENET distribution from about 95% of the spams that are being sent to date and protects the mailing lists completely. Moderation means, however, that someone has to take the time to review each message before it goes out. We have set up software here that simply allows the moderator to forward to an address at net.bio.net messages that (s)he wishes to have distributed. This takes no more time than that needed to read the message and pass it on, say about 1 min. per message. Most newsgroups currently have a discussion leader who is responsible for their newsgroup. The discussions leaders and their e-mail addresses are listed in the BIOSCI Information Sheet which is available on the Web at http://www.bio.net/. If a newsgroup is being hit with too many junk postings, please contact the discussion leader for that group and see if there is interest in moderating the group. Please do not assume that by simply posting a complaint to the newsgroup itself, anyone on the BIOSCI staff will act on your complaint. With close to 100 newsgroups to run, the BIOSCI staff has to rely on the discussion leaders of each newsgroup to report problems directly to us at biosci-help@net.bio.net. We will moderate any of our newsgroups if the discussion leader tells us that the readership of the group wishes to do so and if a moderator is willing to do the work. For most BIOSCI/bionet groups, this entails only a few minutes of work each day. Moderating a newsgroup will resolve probably 95% of the junk postings on the USENET distribution. Unfortunately there are easy ways for determined spammers to override the moderation mechanism on USENET, but we can protect our e-mail subscribers from unwanted postings if the newsgroup is moderated. You can also access our newsgroups over the WWW at URL http://www.bio.net. While this Web interface will not stop spammers from trying to post to the groups, this will give you yet another way, besides using USENET news, to keep the junk out of your personal mail files. For those of you with local USENET news systems, the Web interface will also give you faster access to new newsgroups and recent postings. 3) Examples of subscribing and unsubscribing to the mailing lists. ------------------------------------------------------------------ PLEASE NOTE: The BIOSCI management does NOT act on subscription/unsubscription requests that are posted improperly to the newsgroups and mailing lists. People who do this only bother everyone on the lists to no avail. Please be sure to follow the proper procedures below. Gory details are in the BIOSCI Information sheets on the Web at http://www.bio.net. Below we give an example utilizing the METHODS-AND-REAGENTS list at both of our two BIOSCI sites: Users in the Americas and Pacific Rim countries who use the BIOSCI ------------------------------------------------------------------ node at computer net.bio.net: ---------------------------- A) Determine the "listname" which is the <=8 character mail address ^^^^^^^^^^^^^ for the group. These can be found in the BIOSCI Info. Sheet. For the METHODS-AND-REAGENTS group the mailing address is methods@net.bio.net. The listname is the portion of the address to the left of the @ sign, i.e., "methods". The listname is used with the "subscribe" and "unsubscribe" commands illustrated below. B) Mail all commands in the body of a mail message addressed to biosci-server@net.bio.net. Do NOT send commands to the newsgroup posting addresses! Leave the Subject: line blank, any text on it will be ignored. C) In the body of your message put one or more of the following commands with an "end" command on the last line, e.g., subscribe methods unsubscribe methods end Do NOT put your e-mail address or other text on these lines. The server only allows you to cancel your subscription if the address on your mail header matches the address on our mailing list. Please ask for help at biosci-help@net.bio.net if your address has changed, e.g., if you know you are on the list but the server tells you that you are not a member. Users in Europe, Africa, and Central Asia who use the BIOSCI node at -------------------------------------------------------------------- computer daresbury.ac.uk (also known as dl.ac.uk): ------------------------------------------------- To subscribe and unsubscribe to/from the BIOSCI lists, you need to specify the full USENET newsgroup name with "bionet-news." prepended. The USENET newsgroup names are listed in the BIOSCI Information sheet on the Web at http://www.bio.net/. For the METHODS-AND-REAGENTS list the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the appropriate commands are sub bionet-news.bionet.molbio.methds-reagnts unsub bionet-news.bionet.molbio.methds-reagnts These commands are included in a message addressed to mxt@dl.ac.uk, NOT to the newsgroup mailing addresses. As usual, include the text in the body of the message as text on the Subject: line is ignored. To unsubscribe from all the lists at the UK node, use unsub bionet-news Please note that if the address in the list is different than the one in your mail message header, you will not be able to unsubscribe by this method. If you have problems, please mail biosci@daresbury.ac.uk. 4) The BIOSCI user address and research interest directory. ----------------------------------------------------------- Please take this opportunity to add your name, address, and research interest information to the BIOSCI User Address Database if you have not already done so. You can fill out the address form directly through our Web page at URL http://www.bio.net/adrform.html. The address database is reindexed nightly for WWW access (the URL is http://www.bio.net/). If you are not directly on the Internet but can reach it by e-mail, please use our waismail server to access the user directory. waismail use is described above. You can also request a user address form by e-mail from biosci-help@net.bio.net. Please check your database entry from time-to-time to see if your address information is still up-to-date. Because of our limited personnel resources, we ask that you resubmit a *complete* form to revise your entry; we only replace complete entries and do not have resources to edit old forms. Sincerely, Dave Kristofferson BIOSCI/bionet Manager biosci-help@net.bio.net From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Robert Rej Newsgroups: bionet.diagnostics Subject: Liver Diseases and the Clinical Laboratory: Arnold O. Beckman Conference Date: 12 Nov 1996 07:13:43 -0800 Organization: State Univ NY at Albany, School of Public Health Lines: 90 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a477$gns@net.bio.net> NNTP-Posting-Host: net.bio.net Arnold O. Beckman Conference: Liver Diseases and the Clinical Laboratory 16-17 February 1997, New Orleans, LA Sponsored by: American Association for Clinical Chemistry (See: http://www.aacc.org/meetings/beckman/beckmangeninfo.html) Recent years have brought major advances in the diagnosis and treatment of liver diseases, particularly viral hepatitis. Accurate and rapid diagnosis is essential for appropriate therapy such as the use of alpha interferon and other anti-viral strategies . Recent advances in liver disease will be explored at the 1997 A. O. Beckman Conference with an emphasis on the laboratory's contribution to diagnosis and treatment. Hepatitis and other liver diseases are prevalent health problems. More than 60,000 cases of viral hepatitis are officially reported annually in the U.S. and it is estimated over five-times that number of cases actually occur. Several hepatotropic viruses are associated with a wide spectrum of acute and chronic liver disease syndromes. The mode of action and molecular diagnostics of the hepatitis viruses will be explored at the Conference with an emphasis on both new and well-recognized laboratory techniques. With recent FDA approval of hepatitis A vaccine, laboratorians will need to change interpretation of hepatitis A tests. For hepatitis C infection, the viral RNA levels can be monitored using quantitative PCR, branched chain DNA, or NASBA techniques. Laboratorians continue to search for an accurate and reliable method to quantify hepatic function and the use of model drugs which are metabolized exclusively by the liver by cytochrome P-450 enzyme systems. The application and limitation of these fun ction tests will be explored and evaluated. Excess consumption of ethanol is also a well-recognized public health issue. Recent advances in the mode of action, quantification of hepatic damage, and current therapeutic approaches will be discussed. Liver cancer may be induced by viral hepatitis or cirrhosis. The pathogenesis and the use of alpha-fetoprotein and other markers for liver cancer will be covered. Hemochromatosis and Wilson's disease are important inherited disorders causing acute and chronic liver disease. The laboratory's role in the recognition, investigation, and screening for these diseases will be presented. Liver transplantation has emerged as a treatment for both end-stage chronic liver disease and acute liver failure. The important role of the laboratory in particular for the selection of patients for transplantation and the support of the patien t following liver allografts will be covered. With the large number of laboratory tests available for the diagnosis and estimating severity of liver diseases, the Conference will conclude with an examination of testing algorithms and strategies for the cost-effective application of laboratory procedures. Accommodations A block of rooms is being held for conference attendees at the Fairmont Hotel, New Orleans, Louisiana. One of the nation's truly grand hotels, the Fairmont is located in the heart of the city's convention and business district, convenient to all of the sightseeing destinations and just one block from the world-famous French Quarter. The special conference rate is $137 for a single room and $144 for a double room. Reservations can be made by calling the Fairmont at 800-527-4727 or 504-529-7111. Identify yourself as attending the AACC Beckman Conference to reserve your room at the sp ecial rate. Rooms must be reserved by January 15, 1997, to ensure availability. Official Airlines & Travel Agent AACC and Travel Planners have negotiated special air fares with American and Delta Airlines for Arnold O. Beckman Conference attendees. To make reservations call Travel Planners at 800-221-3531 or 212-532-1660 or call the airlines directly; American: 800 -433-1790. Star File #S8387, AN#0227AB or Delta: 800-241-6760, File # V0267. Be sure to refer to the appropriate file number to obtain the AACC discounts. Call Toll Free 800-892-1400 and register today with VISA, MasterCard or American Express For additional information contact AACC Customer Service 2101 L Street, NW, Suite 202, Washington, DC 20037-1526 800-892-1400 or 202-857-0717 Fax: 202-887-5093 From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Erik Jongert Newsgroups: bionet.diagnostics Subject: Needed: Guinea Pigs / Cattle Cytokine Assays Date: 12 Nov 1996 07:13:16 -0800 Organization: Myself Lines: 15 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a46c$gn8@net.bio.net> NNTP-Posting-Host: net.bio.net Hello, Does anybody know if there are any cytokine assays available for IL-1, IL-4, IL-10 and IFN-g from the guinea pig (or even for cattle)? Or else, can anyone tell me if the nucleotide sequences from these cytokines are available? I will need these to get an idea of the cytokine profiles after vaccination of the animal. I'm currently busy with my PhD. Thanks in advance, ir. Erik Jongert erjonger@is1.vub.ac.be From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: PH.D. SENIOR SCIENTIST WANTED Date: 12 Nov 1996 07:15:42 -0800 Organization: America Online, Inc. (1-800-827-6364) Lines: 50 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a4au$gv5@net.bio.net> NNTP-Posting-Host: net.bio.net Biotechnology company in Houston, Texas has an open position as follows. Job Title: Senior Research Scientist-Biologist Reports to: Research Director (Ph.D.) Summary: Develop and supervise a cell/molecular biology-based research program to further our understanding of the interaction of nucleic acid-derived therapeutics with cells. Develop in vitro and in vivo assay systems and analytical methods to test the activity of oligonucleotides and other therapeutics. Communicate research findings to other scientists and management, and contribute to the strategic research direction of the company. Working within the framework provided by the management, explore the full range of biological research methods to achieve Company goals. Requirements: 1. Must be in the Houston area, no relocation money available (or willing to relocate at your own expense). 2. Ph.D. in cell biology, molecular biology, or biochemistry. 3. 2-4 years of experience postdoctoral. 4. 4-8 years of experience in fundamental research on biochemistry and molecular biology in the fields of immunology or cancer biology. 5. Broad-based training and experience in the development, implementation, and interpretation of in vitro assays. 6. Publications in major, peer reviewed scientific journals. 7. Excellent communication skills. 8. Personal computer skills. 9. Highly motivated TEAM PLAYER. Salary: Commensurate with experience, probable range $45-50K/annum. If you are interested in this position, please submit your resume to the address below. We will furnish a further skill survey for potential candidates to complete to determine qualifications. If you know someone who might be interested in this position, please provide them with a copy of the this message. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. ssihouston@aol.com http://www.net-solutions.com/ScienStaff 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929, FAX: 713-640-1942 From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Peter Scott Newsgroups: bionet.diagnostics Subject: Biology and IT Date: 12 Nov 1996 06:16:14 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 71 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a0re$aec@net.bio.net> NNTP-Posting-Host: net.bio.net Members of this Newsgroup may be interested in a novel Conference organized by the British Society for Plant Pathology and the Systematics Association. (Please excuse some limited cross-posting.) In view of the expected appeal of this meeting to a wide range of biologists and information technologists, the following advertisement has been placed in Nature. It's not too late to register, even though the deadline is around now. It's not expensive. The Open Forum is free to all. Check out the Web page, in which we are providing lots of links as an experiment in the use of the Web to enhance the Conference. ----- CONFERENCE University of Kent, Canterbury, UK 16-19 December 1996 UNLOCKING THE FUTURE For everyone interested in the interface of BIOLOGY and INFORMATION TECHNOLOGY Special subjects - Information Technology in Plant Pathology - Computer-Based Species Identification Open Forum on - BIOLOGY & IT: THE ROAD AHEAD with Professor Sir Robert May Chief Scientific Advisor, UK Office of Science & Technology Professor Peter Cochrane Head of Advanced Applications & Technology, British Telecom Labs Details and Registration http://www.bspp.org.uk/dec96con.htm Dr Peter Jeffries, Research School of Biosciences, University of Kent, Canterbury CT2 7NZ, UK E-mail: p.jeffries@ukc.ac.uk. Tel: +44 (0)1227 764000 ext. 3478, Fax: +44 (0)1227 787465 ----- The Open Forum will be of special interest. You may well know both of the distinguished speakers from radio or television. To be sure of your place at the Conference, Members of BSPP and the Systematics Association are advised to book early. For a programme and booking form, visit the Web site or contact Peter Jeffries (see above). Please say whether you want to attend the Practical and Tutorial Session on 16 December ("Everything you always wanted to know about IT but were afraid to ask"), indicating your preferred topics. Offers of contributions welcome - see above. Peter -- Peter Scott Director, Information Institute, CAB INTERNATIONAL, Wallingford OX10 8DE, UK Tel: +44 1491 832111. Fax: +44 1491 833508 President, British Society for Plant Pathology Work: p.scott@cabi.org http://www.cabi.org Home: peter@scottp.demon.co.uk BSPP: http://www.bspp.org.uk ********************************************************************* Information Technology in Plant Pathology and Systematics BSPP/SA Meeting, University of Kent, 16-19 December 1996 SEE INTERACTIVE PROGRAMME AT http://www.bspp.org.uk/dec96con.htm ********************************************************************* From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: "T.W. Hysell" Newsgroups: bionet.diagnostics Subject: BOVINE LACTOFERRIN Date: 12 Nov 1996 06:15:18 -0800 Organization: Affordable Software Lines: 3 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a0pm$a9f@net.bio.net> NNTP-Posting-Host: net.bio.net Can anyone give me a source for the purchase of bovine lactoferrin. T. W. Hysell DVM Oakdale Animal Hospital Johnson city NY 13790 From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - REGULATORY AFF./ BIOMED DEV. VP/DIR. Date: 12 Nov 1996 07:15:15 -0800 Organization: America Online, Inc. (1-800-827-6364) Lines: 29 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a4a3$gst@net.bio.net> NNTP-Posting-Host: net.bio.net Job Description: Regulatory Affairs Officer, Director or Vice President for Medical Device Company manufacturing catheters. Salary is $70-100 K per year, with bonus and stock options. Prefer either a MD or Ph.D. This is a hands on position, with an assistant. There will be travel and interfacing with multi-site clinical trial personnel to include vascular surgeons, internal radiologists and cardiologists. Must be intimately familiar with all forms of regulatory FDA submissions to include 510(k), IDE, PMA, etc.. We also have an opening for a product development engineer in the medical devices field for a catheter manufacturer. Engineer will make drawings of devices, place in service devices and oversee the production line. The position is in Southern California. Salary range is $45-55K with bonus and stock options after two years. CAD/CAM a plus. If you believe your company maybe of assistance with filling either of these positions and would be willing to work together with ScienStaff, please contact: David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. ssihouston@aol.com http://www.net-solutions.com/ScienStaff 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929, FAX: 713-640-1942 From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Lee Sang Chan Newsgroups: bionet.diagnostics Subject: Looking for company Date: 12 Nov 1996 06:59:44 -0800 Organization: DACOM Internet Service Lines: 44 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a3d0$fcu@net.bio.net> NNTP-Posting-Host: net.bio.net Hellow, I'm with one of biggest pharma corporation in Korea and working on science & information section of diagnostic reagent department. I'm going to quit my jop and establish a trading company for diagnostic products in the near future. I'm ready to start the business and also have partners for selling these products. My partners once worked with me in the same company and they are veteranes who have average 10 year experience for diagnostic products sales. They have already started their own business a few months ago, and I'll join them soon. Since they are managing small company, they can only purchase small quantity of low price products which are suitable for small clinics or hospitals. The product range that we focused on is screening tests, diagnostic reagents, clinical instruments, and ELISA products. So, we thought that it'll be good for us to form a relationship with the company which is under simillar situation with us, that is, the company is small and just started its business so that it's willing to seek mutual development. So, if you are interested in this article, please feel free to contact us with below e-mail address. And additionally, I'm looking for a chemistry analyzer of the level of 1,500-2,000 US$. e-mail address : marcop@bora.dacom.co.kr Lee Sang Chan 1517, Shilim 9-Dong, Kwanak-Ku, Seoul, 151-019, Korea From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: "Jack H. Pincus" Newsgroups: bionet.diagnostics Subject: Re: PSA detection kit? Date: 12 Nov 1996 06:38:44 -0800 Organization: Concentric Network Lines: 15 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a25k$cu2@net.bio.net> NNTP-Posting-Host: net.bio.net On Tue, 05 Nov 1996 15:24:02 -0500, lily wrote: >I am trying to find a commercial supplier of a prostate specific >antigen detection kit for research purposes. Does anyone know where >to find this? > >Kyle MacBeth >macbeth@mpi.com You can purchase the clinical laboaratory product for research use from Hybritech in San Diego, California. -- Jack H. Pincus jhpincus@cris.com From owner-diagnostics@net.bio.net Mon Nov 11 22:00:00 1996 Path: biosci!biosci!not-for-mail From: V J Street Newsgroups: bionet.diagnostics Subject: dna fingerprinting Date: 12 Nov 1996 07:08:14 -0800 Organization: Molecular Biology & Biotechnology, University of Sheffield , UK Lines: 9 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <56a3su$g99@net.bio.net> NNTP-Posting-Host: net.bio.net I am in my third year at the university of Sheffield and am carrying out my dissertation on the validity of dna fingerprinting. Within this I need to find out the various techniques used, how the probabilities of a match are calculated and obviously how valid the technique is. I really need some information on the new National Research Council's report which came out in May of this year, and doesn't seem to be in any journals. Thankyou for your help. Vicki Street From owner-diagnostics@net.bio.net Tue Nov 19 22:00:00 1996 Path: biosci!biosci!not-for-mail From: APOPTOSIS Online Newsgroups: bionet.diagnostics Subject: "APOPTOSIS Onine" Site Announcement Date: 20 Nov 1996 13:54:28 -0800 Organization: ApopNet Lines: 22 Sender: daemon@net.bio.net Approved: kevin@embra.compulink.co.uk Distribution: world Message-ID: <56vumk$h8q@net.bio.net> NNTP-Posting-Host: net.bio.net ApopNet has established a new web site "APOPTOSIS Online: The Apoptosis Information and Communication Center". You will find "APOPTOSIS Online" on the web at: http://www.apopnet.com "APOPTOSIS Online" features an online discussion board, a resume/position depository and a content-based resource center focusing on apoptosis-related information. Access to APOPTOSIS Online is entirely free, requiring only a simple one-time member registration. I hope you find "APOPTOSIS Online" an informative and valuable resource. Webmaster, APOPTOSIS Online From owner-diagnostics@net.bio.net Tue Nov 19 22:00:00 1996 Path: biosci!biosci!not-for-mail From: "Carl M. Good III" Newsgroups: bionet.diagnostics Subject: buyers guide for diagnostic products Date: 20 Nov 1996 13:54:26 -0800 Organization: UltraNet Communications, Inc. Lines: 6 Sender: daemon@net.bio.net Approved: kevin@embra.compulink.co.uk Distribution: world Message-ID: <56vumi$h8k@net.bio.net> NNTP-Posting-Host: net.bio.net I am looking for a place on the WEB that is like a buyers guide for diagnostic products. Any ideas? Thanks Carl From owner-diagnostics@net.bio.net Tue Nov 19 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Dr Dave Smart <100307.2661@compuserve.com> Newsgroups: bionet.diagnostics Subject: 1,1'-biphenyl-4-yl boronic acid Date: 20 Nov 1996 13:54:29 -0800 Organization: Randox Laboratories Ltd. Lines: 6 Sender: daemon@net.bio.net Approved: kevin@embra.compulink.co.uk Distribution: world Message-ID: <56vuml$h8u@net.bio.net> NNTP-Posting-Host: net.bio.net Does anyone out there know the chemical structure of this compound or it's manufacture? We are really keen to find out more. So, if you are a manufacturer or just a keen boffin, please contact us to discuss the subject further. From owner-diagnostics@net.bio.net Tue Nov 19 22:00:00 1996 Path: biosci!biosci!not-for-mail From: Zafer Altin Newsgroups: bionet.diagnostics Subject: ELISA for Alveolar Echinococcus antigen(s)? Date: 20 Nov 1996 13:54:32 -0800 Organization: Antibody Concepts Lines: 14 Sender: daemon@net.bio.net Approved: kevin@embra.compulink.co.uk Distribution: world Message-ID: <56vumo$h93@net.bio.net> NNTP-Posting-Host: net.bio.net We are interested to find out where we can purchase ELISA(preferably) kits for detection of Alveolar Echinococcus antigen(s). Any help is greatly appreciated. end Zafer Altin, Ph.D. Antibody Concepts South San Francisco, CA Tel/Fax: (415) 738 9776 e-mail: zafer@abconcepts.com web site:http://www.abconcepts.com From owner-diagnostics@net.bio.net Tue Nov 19 22:00:00 1996 Path: biosci!biosci!not-for-mail From: "Dr. Wasco" Newsgroups: bionet.diagnostics Subject: Diagnostic Notes - Outlines in Clinical Medicine Date: 20 Nov 1996 13:54:29 -0800 Organization: MindSpring Enterprises Lines: 24 Sender: daemon@net.bio.net Approved: kevin@embra.compulink.co.uk Distribution: world Message-ID: <56vuml$h8s@net.bio.net> NNTP-Posting-Host: net.bio.net A survey of one of my favorite sites has revealed a new resource that may be of interest to medical students/clinicians. If you need a quick, comprehensive overview of including diseases and diagnoses, including symptoms, therapies and summaries, visit the Outlines in Clinical Medicine at Avicenna.com. The OCM are a great resource if you come across specific diseases or symptoms, and may be a "little rusty" on the details. OCM are comprehensive overviews of over 700 topics of special interest to Medical Students, Practitioners, and other clinicians. OCM is now required at Harvard Med., and other medical schools. You can find OCM at: www.avicenna.com in the Clinical References section. J. Wasco, MD